CASP3 and neoplasm: Supressed Prdx activity and enhanced ROS levels by Celastrol correlated with increased levels of cleaved-caspase 3 and ER stress protein CHOP (Figure 5G & H), as well as reduced tumor cell ki-67 immunoreactivity (Figure 5I).